With no evidence to support the claim that 10 children died due to COVID-19 vaccines, experts unpack the impact of CBER chief ...
The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...
Richard Pazdur had clashed with Trump officials on the legality and pace of their initiatives. He could still withdraw his ...
Comments by President Trump, Health Secretary Robert F. Kennedy Jr. and some panelists suggest the committee is likely to ...
The memo was written by Dr. Vinay Prasad, head of the FDA’s vaccine division. In the note to staff, he said the deaths ...
Shares of vaccine makers slide as an internal FDA memo on vaccine safety and plans for stricter rules spark broad pressure across the overall industry.
Dec 2 (Reuters) - The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard ...
The three-dose hepatitis B vaccine has a long track record of safety, but rolling back recommendations could leave kids ...
When the federal vaccine committee hand-picked by anti-vaccine Health Secretary Robert F. Kennedy Jr. meets again this week, ...
Bernstein warned in a note Tuesday that “shock waves are expected at the ACIP meeting this week,” citing a series of unusual developments that could have implications for Merck, Pfizer and Moderna.
Food and Drug Administration chief Marty Makary convinced Rick Pazdur to take the role to help bring stability to the roiling agency.
Longtime FDA oncology leader and newly appointed Center for Drug Evaluation and Research director Richard Pazdur has filed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results